City View Green Holdings Inc. (CVGR.CN)
CAD 0.01
(0.0%)
CAD 0.01
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -2.44 Million CAD | -3.04% |
| 2022 | -2.37 Million CAD | 51.65% |
| 2021 | -4.91 Million CAD | 21.5% |
| 2020 | -6.26 Million CAD | 74.45% |
| 2019 | -24.5 Million CAD | -2453.31% |
| 2018 | -959.7 Thousand CAD | -209.11% |
| 2017 | -310.47 Thousand CAD | -89.67% |
| 2016 | -163.68 Thousand CAD | 6.02% |
| 2015 | -174.16 Thousand CAD | -250.12% |
| 2014 | -49.74 Thousand CAD | 97.73% |
| 2013 | -2.18 Million CAD | -75.2% |
| 2012 | -1.24 Million CAD | 75.78% |
| 2011 | -5.16 Million CAD | -145.94% |
| 2010 | -2.09 Million CAD | -2.53% |
| 2009 | -2.04 Million CAD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -7639.00 CAD | 99.53% |
| 2024 Q2 | -244.32 Thousand CAD | -3098.43% |
| 2023 Q2 | -248.86 Thousand CAD | 20.83% |
| 2023 Q4 | -1.62 Million CAD | -451.04% |
| 2023 FY | -2.44 Million CAD | -3.04% |
| 2023 Q1 | -314.35 Thousand CAD | 39.66% |
| 2023 Q3 | -295.51 Thousand CAD | -18.74% |
| 2022 FY | -2.37 Million CAD | 51.65% |
| 2022 Q4 | -520.93 Thousand CAD | 33.24% |
| 2022 Q3 | -780.28 Thousand CAD | -0.88% |
| 2022 Q2 | -773.46 Thousand CAD | -16.87% |
| 2022 Q1 | -661.83 Thousand CAD | 76.0% |
| 2021 Q2 | -674.3 Thousand CAD | -29.32% |
| 2021 Q4 | -2.75 Million CAD | -312.05% |
| 2021 Q1 | -521.43 Thousand CAD | 77.1% |
| 2021 FY | -4.91 Million CAD | 21.5% |
| 2021 Q3 | -669.38 Thousand CAD | 0.73% |
| 2020 Q1 | -837.54 Thousand CAD | 88.23% |
| 2020 FY | -6.26 Million CAD | 74.45% |
| 2020 Q2 | -422.29 Thousand CAD | 49.58% |
| 2020 Q3 | -2.07 Million CAD | -391.55% |
| 2020 Q4 | -2.27 Million CAD | -9.67% |
| 2019 Q2 | -1.86 Million CAD | 87.27% |
| 2019 Q3 | -956.57 Thousand CAD | 48.61% |
| 2019 Q4 | -7.11 Million CAD | -644.08% |
| 2019 FY | -24.5 Million CAD | -2453.31% |
| 2019 Q1 | -14.62 Million CAD | -11902.69% |
| 2018 Q1 | -642.56 Thousand CAD | -470.01% |
| 2018 Q2 | -115.69 Thousand CAD | 82.0% |
| 2018 Q4 | -121.82 Thousand CAD | -53.01% |
| 2018 FY | -959.7 Thousand CAD | -209.11% |
| 2018 Q3 | -79.61 Thousand CAD | 31.18% |
| 2017 Q3 | -71.24 Thousand CAD | -39.28% |
| 2017 Q2 | -51.15 Thousand CAD | 32.12% |
| 2017 Q1 | -75.35 Thousand CAD | 15.95% |
| 2017 FY | -310.47 Thousand CAD | -89.67% |
| 2017 Q4 | -112.72 Thousand CAD | -58.24% |
| 2016 FY | -163.68 Thousand CAD | 6.02% |
| 2016 Q3 | -21.57 Thousand CAD | 14.32% |
| 2016 Q1 | -26.28 Thousand CAD | 48.08% |
| 2016 Q4 | -89.65 Thousand CAD | -315.6% |
| 2016 Q2 | -25.17 Thousand CAD | 4.19% |
| 2015 Q3 | -33.11 Thousand CAD | -49.54% |
| 2015 Q4 | -50.61 Thousand CAD | -52.87% |
| 2015 FY | -174.16 Thousand CAD | -250.12% |
| 2015 Q2 | -22.14 Thousand CAD | 64.41% |
| 2015 Q1 | -62.21 Thousand CAD | -155.86% |
| 2014 Q4 | 111.39 Thousand CAD | 261.86% |
| 2014 Q3 | -68.81 Thousand CAD | -41.61% |
| 2014 FY | -49.74 Thousand CAD | 97.73% |
| 2014 Q1 | -43.72 Thousand CAD | 97.59% |
| 2014 Q2 | -48.59 Thousand CAD | -11.14% |
| 2013 Q3 | -81.62 Thousand CAD | 32.65% |
| 2013 Q4 | -1.81 Million CAD | -2118.48% |
| 2013 FY | -2.18 Million CAD | -75.2% |
| 2013 Q1 | -157.11 Thousand CAD | 53.23% |
| 2013 Q2 | -121.19 Thousand CAD | 22.86% |
| 2012 Q4 | -335.94 Thousand CAD | 0.25% |
| 2012 Q2 | -303.62 Thousand CAD | -11.02% |
| 2012 Q1 | -273.47 Thousand CAD | -31.02% |
| 2012 Q3 | -336.79 Thousand CAD | -10.93% |
| 2012 FY | -1.24 Million CAD | 75.78% |
| 2011 Q3 | -383.38 Thousand CAD | 90.83% |
| 2011 Q1 | -387.24 Thousand CAD | 31.56% |
| 2011 Q4 | -208.73 Thousand CAD | 45.56% |
| 2011 Q2 | -4.18 Million CAD | -979.8% |
| 2011 FY | -5.16 Million CAD | -145.94% |
| 2010 Q2 | -443.47 Thousand CAD | -4.46% |
| 2010 Q3 | -664.55 Thousand CAD | -49.85% |
| 2010 FY | -2.09 Million CAD | -2.53% |
| 2010 Q4 | -565.81 Thousand CAD | 14.86% |
| 2010 Q1 | -424.53 Thousand CAD | 0.0% |
| 2009 FY | -2.04 Million CAD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Aion Therapeutic Inc. | -6.28 Million CAD | 61.054% |
| Ayurcann Holdings Corp. | -3.96 Million CAD | 38.287% |
| Blueberries Medical Corp. | -1.63 Million CAD | -49.727% |
| The BC Bud Corporation | -1.22 Million CAD | -100.039% |
| BioNxt Solutions Inc. | -7.72 Million CAD | 68.295% |
| CordovaCann Corp. | -6.88 Million CAD | 64.434% |
| Christina Lake Cannabis Corp. | -4.13 Million CAD | 40.738% |
| Captor Capital Corp. | -11.38 Million CAD | 78.485% |
| 1CM Inc. | -913.85 Thousand CAD | -167.94% |
| Global Hemp Group Inc. | -2.58 Million CAD | 5.113% |
| Greenway Greenhouse Cannabis Corporation | -4.72 Million CAD | 48.152% |
| IM Cannabis Corp. | -9.49 Million CAD | 74.22% |
| Lobe Sciences Ltd. | -4.7 Million CAD | 47.984% |
| Maple Leaf Green World Inc. | -1.09 Million CAD | -124.327% |
| Mountain Valley MD Holdings Inc. | -7.67 Million CAD | 68.076% |
| Nextleaf Solutions Ltd. | 223.33 Thousand CAD | 1196.381% |
| Ovation Science Inc. | -813.14 Thousand CAD | -201.125% |
| Pharmadrug Inc. | -13.2 Million CAD | 81.452% |
| Captiva Verde Wellness Corp. | -6.08 Million CAD | 59.761% |
| RAMM Pharma Corp. | -7.72 Million CAD | 68.286% |
| RIV Capital Inc. | -106.76 Million CAD | 97.706% |
| Revive Therapeutics Ltd. | -5.61 Million CAD | 56.42% |
| Red White & Bloom Brands Inc. | -138.89 Million CAD | 98.237% |
| SLANG Worldwide Inc. | -19.36 Million CAD | 87.356% |
| 1933 Industries Inc. | -13.36 Million CAD | 81.678% |
| Red Light Holland Corp. | -7.62 Million CAD | 67.897% |
| Top Strike Resources Corp. | -1.72 Million CAD | -42.357% |
| Xebra Brands Ltd. | -1.95 Million CAD | -25.095% |
| Adastra Holdings Ltd. | -3.54 Million CAD | 30.921% |